Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc transporter ZIP6 (also known as LIV-1 or SLC39A6) is a multi-pass transmembrane protein belonging to the solute carrier family 39 (SLC39) of zinc transporters. It plays a critical role in maintaining intracellular zinc homeostasis by mediating zinc influx from the extracellular space into the cytoplasm. ZIP6 is highly expressed in hormonally controlled tissues such as the breast and prostate, and its expression is upregulated by estrogen. In cancer, ZIP6 is frequently overexpressed, particularly in breast, prostate, and pancreatic cancers, where it promotes epithelial-mesenchymal transition (EMT), cell migration, and metastasis, often by forming a heterodimer with ZIP10. Because of its high expression on the surface of tumor cells and limited expression in normal tissues, ZIP6 has emerged as an attractive target for antibody-drug conjugates (ADCs). Prominent therapeutic candidates targeting ZIP6 include ladiratuzumab vedotin (SGN-LIV1A), which delivers a cytotoxic microtubule inhibitor payload to induce mitotic arrest and apoptosis in cancer cells.
Antibody-drug conjugate (ADC) targeting cell-surface ZIP6 to deliver cytotoxic payloads (such as microtubule inhibitors or topoisomerase I inhibitors), leading to receptor-mediated endocytosis, intracellular drug release, mitotic arrest, and apoptosis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc transporter ZIP6 (LIV-1).